Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Marimed (MRMD) Other Working Capital Changes (2016 - 2025)

Historic Other Working Capital Changes for Marimed (MRMD) over the last 12 years, with Q3 2025 value amounting to $334000.0.

  • Marimed's Other Working Capital Changes fell 3650.19% to $334000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$196000.0, marking a year-over-year increase of 9315.64%. This contributed to the annual value of -$883000.0 for FY2024, which is 8037.78% up from last year.
  • Latest data reveals that Marimed reported Other Working Capital Changes of $334000.0 as of Q3 2025, which was down 3650.19% from $189000.0 recorded in Q2 2025.
  • Over the past 5 years, Marimed's Other Working Capital Changes peaked at $3.2 million during Q4 2022, and registered a low of -$3.5 million during Q3 2023.
  • For the 5-year period, Marimed's Other Working Capital Changes averaged around $51947.4, with its median value being $268000.0 (2021).
  • In the last 5 years, Marimed's Other Working Capital Changes surged by 125625.0% in 2021 and then tumbled by 60099.15% in 2023.
  • Marimed's Other Working Capital Changes (Quarter) stood at -$773000.0 in 2021, then surged by 519.92% to $3.2 million in 2022, then plummeted by 175.79% to -$2.5 million in 2023, then soared by 80.53% to -$479000.0 in 2024, then surged by 169.73% to $334000.0 in 2025.
  • Its Other Working Capital Changes was $334000.0 in Q3 2025, compared to $189000.0 in Q2 2025 and -$240000.0 in Q1 2025.